ImmuCell (ICCC) Set to Announce Quarterly Earnings on Thursday

ImmuCell (NASDAQ:ICCC) is set to announce its earnings results after the market closes on Thursday, May 9th. Investors that wish to register for the company’s conference call can do so using this link.

ImmuCell (NASDAQ:ICCC) last issued its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter. The firm had revenue of $5.10 million for the quarter. ImmuCell had a negative return on equity of 21.79% and a negative net margin of 33.05%.

ImmuCell Stock Up 1.2 %

Shares of ICCC opened at $5.09 on Tuesday. The stock has a market capitalization of $39.80 million, a price-to-earnings ratio of -6.79 and a beta of 0.60. ImmuCell has a 1 year low of $4.26 and a 1 year high of $6.05. The business’s 50 day simple moving average is $5.15 and its 200-day simple moving average is $5.01. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.73 and a quick ratio of 0.87.

ImmuCell Company Profile

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.